Stay updated on Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Sign up to get notified when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.

Latest updates to the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.6.6 updated from v3.6.5 on the page, indicating a small maintenance update to the study details page.SummaryDifference0.0%

- Check12 days agoChange DetectedA funding identifier '2015 ( U.S. NIH Grant/Contract )' was added to the Study ID Numbers. This adds NIH funding attribution to the study record but does not change the study design or participant criteria.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, representing a minor metadata/template update to the page without altering study content or results.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a new version of the page's documentation or UI. This change does not alter substantive content.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision on the page updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a small page update and refresh of the study record.SummaryDifference0.0%

- Check70 days agoChange DetectedA new revision tag v3.6.2 was added, replacing the previous v3.6.0 to indicate a newer version of the page or its underlying system. This signals a minor update to the page’s framework or content.SummaryDifference0.0%

Stay in the know with updates to Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.